Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4YUW

Crystal structure of Trypanosoma cruzi spermidine synthase in complex with trans-4-methylcyclohexylamine

Summary for 4YUW
Entry DOI10.2210/pdb4yuw/pdb
Related4YUV 4YUX 4YUY 4YUZ 4YV0 4YV1 4YV2
DescriptorSpermidine synthase, putative, 5'-[(S)-(3-AMINOPROPYL)(METHYL)-LAMBDA~4~-SULFANYL]-5'-DEOXYADENOSINE, trans-4-methylcyclohexanamine, ... (4 entities in total)
Functional Keywordsmethyltransferase, polyamine synthesis, transferase
Biological sourceTrypanosoma cruzi (strain CL Brener)
Total number of polymer chains2
Total formula weight69146.74
Authors
Amano, Y.,Tateishi, Y. (deposition date: 2015-03-19, release date: 2015-09-09, Last modification date: 2023-11-08)
Primary citationAmano, Y.,Namatame, I.,Tateishi, Y.,Honboh, K.,Tanabe, E.,Niimi, T.,Sakashita, H.
Structural insights into the novel inhibition mechanism of Trypanosoma cruzi spermidine synthase.
Acta Crystallogr.,Sect.D, 71:1879-1889, 2015
Cited by
PubMed Abstract: Trypanosoma cruzi causes Chagas disease, a severe disease affecting 8-10 million people in Latin America. While nifurtimox and benznidazole are used to treat this disease, their efficacy is limited and adverse effects are observed. New therapeutic targets and novel drugs are therefore urgently required. Enzymes in the polyamine-trypanothione pathway are promising targets for the treatment of Chagas disease. Spermidine synthase is a key enzyme in this pathway that catalyzes the transfer of an aminopropyl group from decarboxylated S-adenosylmethionine (dcSAM) to putrescine. Fragment-based drug discovery was therefore conducted to identify novel, potent inhibitors of spermidine synthase from T. cruzi (TcSpdSyn). Here, crystal structures of TcSpdSyn in complex with dcSAM, trans-4-methylcyclohexylamine and hit compounds from fragment screening are reported. The structure of dcSAM complexed with TcSpdSyn indicates that dcSAM stabilizes the conformation of the `gatekeeping' loop to form the putrescine-binding pocket. The structures of fragments bound to TcSpdSyn revealed two fragment-binding sites: the putrescine-binding pocket and the dimer interface. The putrescine-binding pocket was extended by an induced-fit mechanism. The crystal structures indicate that the conformation of the dimer interface is required to stabilize the gatekeeping loop and that fragments binding to this interface inhibit TcSpdSyn by disrupting its conformation. These results suggest that utilizing the dynamic structural changes in TcSpdSyn that occur upon inhibitor binding will facilitate the development of more selective and potent inhibitors.
PubMed: 26327378
DOI: 10.1107/S1399004715013048
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.97 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon